Aim: To study integrity and timing characteristics of traditional Chinese medicine, we used the non-linear fitting ability of BP neural network to establish the relationship mathematical model for evaluation anti-inflammatory effects of Shaoyao and Gancao decoction. Methods: Carrageenan into the foot of rats induced an acute inflammatory response with swelling foot and infiltration of neutrophils. The time-effect relationship of the indicators was studied after Shaoyao and Gancao decoction treatment. BP neural network was used to fit curves of the time-effect relationship of the paw edema , MPO, COX-2, and PGE 2 . Results: The result showed that the change of each inflammation indicator (foot volume, MPO, COX-2, and PGE 2 ) was different at different time points after Shaoyao and Gancao decoction treatment. So it is necessary to fit the time-effect curves by BP neural network. According the fitting curve, the time window, E max , and T max of different inflammation indicator were calculated to evaluate integrity and timing characteristics of anti-inflammatory effects. Conclusion: It demonstrated that various pharmacodynamic indicators have the timing characteristics. The efficacy data is more reliable on neural network nonlinear fitting. It has the significant advantage in the study of the characteristics of integrity and timing characteristics of traditional Chinese medicine. Keywords: Shaoyao and Gancao decoction; anti-inflammatory effects; BP neural network; time-effect curve Acknowledgements: This work was supported by the National Natural Science Foundation of China (No 81060373).
S4.2 Development status of fixed-dose combination finished pharmaceutical products
Li-na CHEN, Bing-xiang YUAN. Department of Pharmacology, College of Medicine, Xi'an Jiaotong University, Xi'an 710061, China Fixed-dose combination finished pharmaceutical products (FDC-FPPs, FDCs) are fixed dose preparations with at least two active components. The objective of FDCs is to improve and enhance the whole effects in vivo using the beneficial factors of drug interactions. Development of FDCs has become one of the breakthrough strategies for removing the bottlenecks in drug discovery. The principle of formulating prescription is taking full advantage of the drugs' effects with a same remedy goal, then proceeding a demonstration of the prescription and multi-factor and multi-level analyses, verifying of clinical combinations, confirming of the goal prescription, finally accessing the normalize research and trials of new drug development. The whole process of FDCs research and development (pharmacy, pharmacodynamics, pharmacokinetics, toxicology and clinical trials) is as strict as such of the complete innovative drugs, and need to optimize the formula and the ratio of prescription. There are currently no unified FDCs registration laws and regulations in the world. According to the characteristics and technical content of FDCs, WHO issued the guidelines for registration of fixed-dose combination medicinal products, registered classification of FDCs could be divided into four categories. Governments and scientists in the world pay more and more attention to the development of FDCs. Grasping independent innovation research and the patents application is the only way for the development of FDCs in China. Keywords: FDCs; drug interactions; registered classification of FDCs; development status Acknowledgements: This work was supported by the National Natural Science Youth Foundation of China (No 30901808) and the Technology and Innovation Project of Shaanxi Province (No 2011KTCL03-20 The main aim is to observe the changes in major pharmacological effect and safety of Chinese Meteria Medica injection (CMMI) when the macromolecular substances in them are removed. Methods: Two kinds of CMMI (Qingkailing Zhusheye and Shuanghuanglian Zhusheye) were bought from market. The macromolecular substances were removed by molecular sieves, and two kinds of CMMI free of macromolecular substances and two kinds of CMMI rich in macromolecular substances were obtained. The fingerprinting maps of CMMI free of macromolecular substances were detected by HPLC, the antipyretic effect of them was assayed in rabbit fever model caused by lipopolysaccharide, and the normal toxicity or allergic toxicity were detected according to Chinese Pharmacopoeia (2010 edition, Book One). Results: Comparing with the fingerprinting map of original CMMI, the change of that from CMMI free of macromolecular substances was less than 5%, their antipyretic effect was almost not changed or even stronger, and the CMMI rich in macromolecular substances showed normal toxicity or allergic toxicity. Conclusion: The safety of CMMI can be improved by removing some macromolecular substances without its pharmacological effect weaken or lost. Keywords: Chinese meteria medica injection; security; macromolecule S4. To set up the cell based assay for screening human interleukin-6 receptor antagonists. Methods: Full length of human interleukin-6 receptor α chain gene was reconstructed in plasmid pTaglite-SNAP (purchased from Cisbio Bioassays) which is a commercialized eukaryotic expression vector can express the receptor interested at the cell surface. Recombinant plasmid was analyzed and identified by restriction enzyme and sequencing. The correct expression vector was incubated with Lipofectamine ® 2000 Reagent (invitrogen), and then transfected into HEK293A
cell. Immunofluorescence and western blot analysis were used to detect the expression level of membrane receptor after 36 h. Cellular ELISA experimentation was analyzed through interaction between interleukin-6 and membrane receptor.
Results:
The results of sequence analysis demonstrated that interleukin-6 receptor gene had been restructured correctly in expression vector pTaglite-SNAP.
Immunofluorescence and western blot analysis indicated that recombinant plasmid could be transfected into HEK293A cell successfully and the transfected cell could express highly membrane interleukin-6 receptor compared with normal control group. Cellular ELISA test showed that interleukin-6 (0.56-36 ng/μL) could bind with membrane receptor in a dose-dependent manner. Parkville, Victoria, 3010 , Australia 5-HT is unique among monoamines as its effects are subserved by at least 13 G-protein-coupled receptors (GPCRs) and one (of a family of 5 gene products) ligand-gated ion channel(s), the 5-HT 3 receptor. 5-HT receptors form 7 distinct classes (5-HT 1-7 ) based on structural/operational/signalling features. A great degree of diversity shows multiple pathways to be activated by a single receptor, allowing compounds to induce functional selectivity/biased signalling. Coupled with the actions of an avid and efficient reuptake system, this array of receptor subtypes provides almost limitless signalling capabilities. Further, posttranslational modifications eg alternate splicing and RNA editing, increase the number of receptor variants, and oligomerisation/heteromerisation increase the number of potential receptor complexes. Whether all these possibilities are used in vivo under physiological or pathological conditions remains to be seen. We will attempt to summarize 5-HT receptor diversity and its impact for disease and drug design. Structural biology and therefore structure based-drug design may become reality, Aim: Molecular descriptor is context-dependent, that is, the various interpretations of a specific molecular descriptor depend on the varying biological contexts. For example, molecular dipole can stand for its binding affinity or drug membrane transport. To clearly understand the descriptor-action relationship, our aim is to elaborate systematically the relationship between molecular descriptor and subcellular drug action, herein, limited in the ligand cellular system of nuclear receptors. Methods: To determine the most crucial factor between cell-free and cell-based systems of drug testing. Such two types of data from cell-free and cellbased assays were collected. The four ligand cellular systems related to nuclear receptors include estrogen analogs, androgen analogs, progestagen analogs and clucocorticoid analogs. The working equation in the context is "cell-based data=a (cell-free data)+b (descriptor to be chosen)+c". The top captured descriptors stand for the difference between cell-free and cell-based system. Results: The most frequent top captured descriptors for such four kinds of analogs are polar surface area, polar solvent accessible surface or the related, highlighting the similar critical drug action in the ligand cellular system of nuclear receptors. Moreover, it is interesting to note that those descriptors have been proved to be extremely correlated with the drug action of membrane transport. Conclusion: We can therefore step by step squeeze out the descriptor-drug-action relationship inside the ligand cellular system of nuclear receptor, leading to the identification of critical drug action. In the end, the whole picture of mapping molecular descriptor onto subcellular drug action is thus able to be established. Keywords: molecular-descriptor-drug-action relationship; ligand cellular system; nuclear receptor; drug action of membrane transport S4.9 Zebrafish-based traditional Chinese medicine (TCM) drug discovery and assessment platform Chun-qi LI*, Yong ZHANG, Jian-hui HE, Jun-jing ZHU, Xiao-yu ZHU, Juan ZHOU. Hunter Biotechnology, Inc, Hangzhou China * To whom correspondence should be addressed.
Zebrafish as a vertebrate animal model is increasingly used for in vivo drug discovery and for assessing compound toxicity and safety, for its several compelling experimental advantages including transparency, high throughput, short test period, low cost, small amount of compound required, easy manipulation and so on. Traditional Chinese medicine usually are complex mixtures comprising of multicomponent and have multi-targets, the traditional in vitro and in vivo drug research approaches are not very suitable for TCM. In present study, we used zebrafish to assess TCM (eg liquid, powder, pill and ointment) toxicity and safety; and build several zebrafish models of human diseases for TCM pharmacology study and new treatment indications research. zebrafish models could be used for assessing TCM toxicity and safety including acute toxicity, development toxicity & teratogenicity, cardiovascular toxicity, liver toxicity, renal toxicity, nerve toxicity, bone toxicity, reproductive toxicity and anaphylactoid reaction, and have a overall predictivity ≥80%; and zebrafish models of human diseases are also very useful for TCM drug discovery including anti-and pro-angiogenesis models, cancer models, cardiovascular disease models, CNS disease models, liver and metabolic disease models, inflammatory and bone disease models, aging models, visual and otoprotectant models, skin care model and target therapy models. Zebrafish TCM drug discovery platform can reduce the time and cost required for the drug development process, increase the compound success rate and decrease the failure ratio due to adverse side effects throughout the drug research and development process.
S4.10
The temperature (25 °C). The Z' factor of the assay was 0.7, which demonstrated its robustness and reliability. 100 compounds from 21,758 compounds were selected by virtural screening for drug screening. As a result, 14 among them exhibited significant CLK1 inhibitory activities. The further study on their in vitro antiinfluenza virus activty showed that they all down regulated the protein expression level of M2 in the A/PR/8/34 (H1N1) influenza virus infected A549 cells in a dose dependent manner at the concentration 0.4-10 μg/mL. Conclusion: As one of the host factors essential for influenza virus replication, CLK1 is a potential drug target for anti-influenza virus drugs, which involved in the alternative splicing of viral M2 pre-mRNA. CLK1 inhibitors might inhibit the viral replication through down regulating the expression of M2 mRNA. Our study on CLK1 protein expression, CLK1 activity assay and rational CLK1 inhibitor discovery will lay important theory and experiment foundation for the anti-influenza drug development, and provide guidance to the study of other host factors related with influenza virus. Keywords: Host cell factor; CDC-like kinase 1 (CLK1); influenza virus; virtual screening; drug discovery Acknowledgements: This work was supported by the National Great Science and Technology Projects (2012ZX09301002) and the International Collaboration Project (2011DFR31240).
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Rational drug screening on neuraminidase (NA) inhibitors of influenza virus using support vector machine (SVM) Ai-lin LIU, Chao LI, Guan-hua DU. However, reliable models for predicting NA inhibitors are rare. In this study, several computational models were built, and used to guide new drug discovery from our compound library. Methods: Based on the data set with 776 distinct structures, several computational models were built to predict whether or not a compound is a NA inhibitor. Each molecule was represented by ADRIANA.
Code. The models were built using a support vector machine (SVM) and a Kohonen's self-organizing map (SOM). The virtual screening of our compoud library was carried out using the better model, and the NA inhibition of the selected compounds was evaluated. Results: One SVM model and one SOM model were built and verified by the test data set, the correct prediction rate of the two models were 95.72% and 91.44%, respectively, so the better model-SVM model was chose to perform virtual screening of our partial compoud library with 65571 compounds, and 560 compounds were predicted as active compounds, which were evaluated by NA activity assay, the assay results showed that 51 compounds displayed NA inhibitory activity, two among them exhibited the highest activity with IC 50 values less than 20 nmol/L. Conclusion: For the first time, one model was built using SVM and successfully used in the rational drug screening on NA inhibitors of influenza virus, several active compounds with novel structures were discovered. This study will provide important information for drug design and drug development. The nightmare of multi-drug resistant bacteria will still haunt if no panacea is ever found. Efforts on seeking desirable natural products with bactericidal property and screening chemically modified derivatives of traditional antibiotics have lagged behind the emergence of new multi-drug resistant bacteria. The concept of using antisense antibiotics, now as revolutionary as is on threshold has experienced ups and downs in the past decade. In the past five years, however, significant technology advances in the fields of microbial genomics, structural modification of oligonucleotides and efficient delivery system have led to fundamental progress in the research and in vivo application of this paradigm. The wealthy information provided in the microbial genomics era has allowed the identification and/ or validation of a number of essential genes that may serve as possible targets for antisense inhibition; antisense oligodeoxynucleotides (ODNs) based on the 3rd generation of modified structures, eg, peptide nucleic acids (PNAs) and phosphorodiamidate morpholino oligomers (PMOs) have shown great potency in gene expression inhibition in a sequence-specific and dose-dependent manner at low micromolar concentrations; and cell penetrating peptide mediated delivery system has enabled the effective display of intracellular antisense inhibition of targeted genes both in vitro and in vivo. The new methods show promise in the discovery of novel gene-specific antisense antibiotics that will be useful in the future battle against drug-resistant bacterial infections. Cdk5 is an a typical cyclin-dependent kinase localized in the brain, and its activity is dependent upon binding to p35. Cdk5/p35 plays an important role in the hyperphosphorylation of tau protein, which has been observed in Alzheimer's Disease (AD) patients. Cdk5/p35 represents an attractive drug target in AD. In this study, we aim to find the inhibitors of cdk5/p35 using virtual screening technology. Methods: A total of 23 266 compounds were filtered by using Lipinski's rule of five to make them more drug-like. Then 6 known representative cdk5/ p35 inhibitors were used to develop common feature pharmacophore models. The enrichment factor calculation was performed to validate the predictive ability of the top 1 model. After the model validation, the top 1 model was employed as a 3D search query to screen compounds that passed Lipinski's rule. Furthermore, the hit compounds were subsequently subjected to docking studies to refine the retrieved hits. Results: A total of 16 383 compounds passed Lipinski's rule. The best pharmacophore model contains five features: two hydrogen-bond donors (D), two ring aromatic features (R), and one hydrophobic aliphatic moiety (L). The enrichment factor (EF) of test set (including 286 inhibitors and 40000 non-inhibitors) is 12.4, which shows the pharmcophore model has a high predictive ability. A total of 1604 compounds can match at least four features of the best pharmacophore, and the hit compounds were subsequently subjected to docking studies to retrieved hits. Zebrafish as a vertebrate animal model is increasingly used for in vivo drug discovery and for assessing compound toxicity and safety and numerous studies confirm that mammalian and zebrafish physiology, development, metabolism and pathways are strikingly similar and that zebrafish is extremely predictive of mammalian responses. This convenient and predictive animal model offers several compelling experimental advantages including transparency, high throughput, short test period, low cost, small amount of compound required, easy manipulation, direct compound dilivery, and so on. FDA and EMEA have accepted zebrafish toxicity and safety assessment data for IND approval and more than one dozen of new drugs discovered primarily based on zebrafish model are now in clinical trials. An important recent development impacting wider use of zebrafish is that the OECD is developing standards for using zebrafish to assess chemical toxicity and the European Union anacted Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) that requires toxicity assessment using animal testing including zebrafish for any chemical imported or manufactured in the region. In this presentation, I will briefly introduce: (1) the background of zebrafish drug screening and compound assessment; (2) zebrafish models for assessing compound toxicity and safety including acute toxicity, LC 50 , nanotoxicity, development toxiciy & teratogenicity, cardiovascular toxicity, liver toxicity, renal toxicity, nerve toxicity, behavior toxicity, bone toxicity, blood toxicity, skin and muscle toxicity, visual toxicity, ototoxicity, gene toxicity, reproductive toxicity and anaphylactoid reaction; and (3) zebrafish models of human diseases for drug discovery including antiand pro-angiogenesis models, cancer models, cardiovascular disease models, CNS disease models, liver and metabolic disease models, inflammatory and bone disease models, aging models, visual and otoprotectant models, skin care model and target therapy models. Zebrafish drug discovery platform can reduce the time and cost required for the drug development process, increase the compound success rate and decrease the failure ratio due to adverse side effects throughout the drug research and development process. Keywords: Zebrafish; toxicity assay; safety assessment; disease model; drug discovery
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The role and molecular mechanism of antibacterial enhancer Hong ZHOU. Aim: Two fractions (A, B 3 ) of XYS were demonstrated to be the active fractions which possessed the antidepressant-like effects in our previous study. In this paper, The compatibility of A and B 3 were used to screen the best prescription group, and the active compounds were screened by spectrum-activity relationship based on rat model of chronic unpredictable mild stress (CUMS). Methods: Behavior research and metabonomics method were used for efficacy study of different compatibility groups. Each group was chemically analyzed using Gas Chromatography and Mass Spectrometry (GC-MS) and bioassayed using behavioral indicators and the contents of plasma metabolic markers. The spectrum-effect relationships were analyzed with multivariate correlation analysis. Results: In the behavior research and pattern recognition analysis of plasma metabolites, When A and B 3 both were 92.6 g herb/kg, compatibility group shows the best antidepressant effect. Close correlation existed in the spectrum-effect relationships, 6 compounds which might contribute to the antidepressant-like effects were selected. Conclusion: This work provides a general model of the combination of chromatographic analysis and pharmacological effect to study the spectrum-effect relationships based on compatibility of active fractions. Keywords: Xiaoyaosan; compatibility; spectrum-effect relationship
